A new study found that solriamfetol, a medication approved by the US Food and Drug Administration (FDA) for several sleep conditions like narcolepsy and sleep apnea, has properties that can treat ADHD symptoms. Craig Surman, MD, director of the clinical and research program in adult ADHD at Massachusetts General Hospital and associate professor at Harvard…

Adults with attention-deficit/hyperactivity disorder (ADHD) are nearly three times more likely to develop dementia than adults without ADHD, according to a Rutgers study. The study, coauthored by Michal Schnaider Beeri, director of the Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center at Rutgers Brain Health Institute (BHI) was published in JAMA Network Open. It followed more…

Sam Bankman-Fried’s quirks helped make him famous. Could they excuse his alleged crimes?

In this episode of MEDcast, the expert panelists review newest guidance for prescription of controlled substances using telemedicine, ADHD medication shortage, and approved and emerging stimulants and non-stimulants for the treatment of ADHD.

Climate change poses a particular threat to children and youth, starting before birth and potentially derailing the normal development of physiological systems, cognitive abilities and emotional skills in ways that are sometimes irreversible, according to a report released by the American Psychological Association and ecoAmerica.

Adults with atopic dermatitis (AD) had a significantly higher prevalence of anxiety, depression, and obsessive-compulsive disorder (OCD) across all severities of the skin disorder, a large retrospective analysis showed. The strongest association was with OCD, which occurred almost 50% more often in patients with AD. Anxiety and depression were more modestly elevated (14% higher) but…

The rapid transition to virtual care that occurred with the onset of the COVID-19 pandemic resulted in better continuity of psychotherapy visits compared to prior to the pandemic when almost all visits were in-person, according to new research published in Psychiatric Services. In addition, the time between appointments grew shorter after the transition to virtual…

Over the past 40 years, the number of students in special education has doubled due to better identification and less stigma, experts said.

OMAHA, Neb. (WOWT) – During an ongoing national shortage for drugs used to treat attention-deficit-hyperactivity disorder (ADHD), one manufacturer is suing the federal government. A New York-based law firm representing Ascent Pharmaceuticals, Inc. said the Drug Enforcement Administration is keeping its client from manufacturing generic prescriptions to treat ADHD.

The Biden administration on Friday extended flexibilities regarding controlled substances to be prescribed via telemedicine. The Drug Enforcement Administration (DEA) said in a notice it would allow providers to continue using telemedicine to prescribe certain controlled substances through the end of 2024.

Nearly 1 in 5 children receiving care in a pediatric headache clinic had significant attention difficulties yet lacked a diagnosis of attention-deficit/hyperactivity disorder (ADHD), according to a poster presented at the 52nd Child Neurology Society Annual Meeting in Vancouver, British Columbia, Canada.

Edward Krumpotich, a drug policy consultant based in Minnesota, was diagnosed with severe attention deficit hyperactivity disorder at age 15 — but he didn’t get help for it until he was 37. In the interim years he suffered from methamphetamine addiction, which he later realized was driven by attempts to self-medicate his untreated A.D.H.D. He…